Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?
AIMS: Undifferentiated (anaplastic) pancreatic cancer and undifferentiated pancreatic carcinoma with osteoclast-like giant cells (giant cell tumour) are rare variants of pancreatic ductal adenocarcinoma. Representing biologically highly aggressive neoplasms, they are frequently diagnosed at an advan...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2010 Mar
|
| In: |
Histopathology
Year: 2010, Jahrgang: 56, Heft: 4, Pages: 440-448 |
| ISSN: | 1365-2559 |
| Online-Zugang: |
|
| Verfasserangaben: | Frank Bergmann, Gerhard Moldenhauer, Esther Herpel, Matthias M. Gaida, Oliver Strobel, Jens Werner, Irene Esposito, Susanne Sebens Müerköster, Peter Schirmacher & Michael A. Kern |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1831531305 | ||
| 003 | DE-627 | ||
| 005 | 20230710161738.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230119s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1365-2559.2010.03499.x |2 doi | |
| 035 | |a (DE-627)1831531305 | ||
| 035 | |a (DE-599)KXP1831531305 | ||
| 035 | |a (OCoLC)1389822205 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bergmann, Frank |d 1972- |e VerfasserIn |0 (DE-588)124407900 |0 (DE-627)363326081 |0 (DE-576)294157840 |4 aut | |
| 245 | 1 | 0 | |a Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer |b putative therapeutic targets? |c Frank Bergmann, Gerhard Moldenhauer, Esther Herpel, Matthias M. Gaida, Oliver Strobel, Jens Werner, Irene Esposito, Susanne Sebens Müerköster, Peter Schirmacher & Michael A. Kern |
| 246 | 3 | 3 | |a Expression of L one CAM, COX- two, EGFR, c-KIT and Her two/neu in anaplastic pancreatic cancer$dputative therapeutic targets? |
| 264 | 1 | |c 2010 Mar | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.01.2023 | ||
| 520 | |a AIMS: Undifferentiated (anaplastic) pancreatic cancer and undifferentiated pancreatic carcinoma with osteoclast-like giant cells (giant cell tumour) are rare variants of pancreatic ductal adenocarcinoma. Representing biologically highly aggressive neoplasms, they are frequently diagnosed at an advanced stage. The response to established chemo- or radiochemotherapeutic treatment regimens is poor, and undifferentiated pancreatic cancer generally has a dismal prognosis. As additional therapeutic options have not yet been investigated in undifferentiated pancreatic cancer, the aim was to analyse the expression of putative therapeutic targets that have shown promising results in various other neoplasms. - METHODS AND RESULTS: Fifteen cases of undifferentiated pancreatic cancer (seven containing osteoclast-like giant cells) were investigated clinicopathologically and immunohistochemically for putative therapeutic targets. Whereas L1CAM, cyclooxygenase (COX)-2 and epidermal growth factor receptor (EGFR) were found to be significantly expressed in 80%, 93% and 87% of the investigated tumours, respectively, there was no substantial expression of c-kit (CD117) and there was no detectable expression of Her2/neu. - CONCLUSIONS: The expression of L1CAM, COX-2 and EGFR in the majority of undifferentiated pancreatic carcinomas suggests that they might represent targets for adjuvant therapy in anaplastic pancreatic cancer. On the other hand, c-kit and Her2/neu seem to have no relevance for the therapy of these tumours. | ||
| 650 | 4 | |a Adenocarcinoma | |
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Cyclooxygenase 2 | |
| 650 | 4 | |a ErbB Receptors | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Middle Aged | |
| 650 | 4 | |a Neural Cell Adhesion Molecule L1 | |
| 650 | 4 | |a Pancreatic Neoplasms | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Proto-Oncogene Proteins c-kit | |
| 650 | 4 | |a Receptor, ErbB-2 | |
| 650 | 4 | |a Retrospective Studies | |
| 700 | 1 | |a Moldenhauer, Gerhard |e VerfasserIn |0 (DE-588)1054128634 |0 (DE-627)791055701 |0 (DE-576)410008443 |4 aut | |
| 700 | 1 | |a Herpel, Esther |d 1973- |e VerfasserIn |0 (DE-588)12965227X |0 (DE-627)476593662 |0 (DE-576)297767984 |4 aut | |
| 700 | 1 | |a Gaida, Matthias |d 1982- |e VerfasserIn |0 (DE-588)139102620 |0 (DE-627)703207377 |0 (DE-576)309804523 |4 aut | |
| 700 | 1 | |a Strobel, Oliver |d 1974- |e VerfasserIn |0 (DE-588)123658977 |0 (DE-627)706385101 |0 (DE-576)293812357 |4 aut | |
| 700 | 1 | |a Werner, Jens |d 1966- |e VerfasserIn |0 (DE-588)120690764 |0 (DE-627)704926717 |0 (DE-576)292340249 |4 aut | |
| 700 | 1 | |a Esposito, Irene |d 1972- |e VerfasserIn |0 (DE-588)133482677 |0 (DE-627)638031826 |0 (DE-576)332396282 |4 aut | |
| 700 | 1 | |a Sebens, Susanne |e VerfasserIn |0 (DE-588)12186054X |0 (DE-627)524700494 |0 (DE-576)292923392 |4 aut | |
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 700 | 1 | |a Kern, Michael A. |d 1968- |e VerfasserIn |0 (DE-588)120548283 |0 (DE-627)080740987 |0 (DE-576)292272545 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Histopathology |d Oxford [u.a.] : Wiley-Blackwell, 1977 |g 56(2010), 4, Seite 440-448 |h Online-Ressource |w (DE-627)320454347 |w (DE-600)2006447-0 |w (DE-576)091142784 |x 1365-2559 |7 nnas |a Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer putative therapeutic targets? |
| 773 | 1 | 8 | |g volume:56 |g year:2010 |g number:4 |g pages:440-448 |g extent:9 |a Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer putative therapeutic targets? |
| 951 | |a AR | ||
| 992 | |a 20230119 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 120548283 |a Kern, Michael A. |m 120548283:Kern, Michael A. |d 50000 |e 50000PK120548283 |k 0/50000/ |p 10 |y j | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 998 | |g 120690764 |a Werner, Jens |m 120690764:Werner, Jens |d 910000 |d 910200 |e 910000PW120690764 |e 910200PW120690764 |k 0/910000/ |k 1/910000/910200/ |p 6 | ||
| 998 | |g 123658977 |a Strobel, Oliver |m 123658977:Strobel, Oliver |d 910000 |d 910200 |d 50000 |e 910000PS123658977 |e 910200PS123658977 |e 50000PS123658977 |k 0/910000/ |k 1/910000/910200/ |k 0/50000/ |p 5 | ||
| 998 | |g 139102620 |a Gaida, Matthias |m 139102620:Gaida, Matthias |d 910000 |d 912000 |e 910000PG139102620 |e 912000PG139102620 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 998 | |g 12965227X |a Herpel, Esther |m 12965227X:Herpel, Esther |d 910000 |d 912000 |e 910000PH12965227X |e 912000PH12965227X |k 0/910000/ |k 1/910000/912000/ |p 3 | ||
| 998 | |g 1054128634 |a Moldenhauer, Gerhard |m 1054128634:Moldenhauer, Gerhard |d 50000 |e 50000PM1054128634 |k 0/50000/ |p 2 | ||
| 998 | |g 124407900 |a Bergmann, Frank |m 124407900:Bergmann, Frank |d 910000 |d 912000 |d 50000 |e 910000PB124407900 |e 912000PB124407900 |e 50000PB124407900 |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1831531305 |e 4249834204 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"9 S."}],"recId":"1831531305","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 19.01.2023"],"title":[{"title":"Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer","title_sort":"Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer","subtitle":"putative therapeutic targets?"}],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010 Mar"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"volume":"56","year":"2010","extent":"9","text":"56(2010), 4, Seite 440-448","issue":"4","pages":"440-448"},"title":[{"title":"Histopathology","title_sort":"Histopathology","subtitle":"journal of the British Division of the International Academy of Pathology"}],"id":{"zdb":["2006447-0"],"doi":["10.1111/(ISSN)1365-2559"],"eki":["320454347"],"issn":["1365-2559"]},"corporate":[{"display":"International Academy of Pathology","role":"isb"}],"pubHistory":["1.1977 -"],"origin":[{"dateIssuedKey":"1977","dateIssuedDisp":"1977-","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell"}],"disp":"Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer putative therapeutic targets?Histopathology","physDesc":[{"extent":"Online-Ressource"}],"recId":"320454347"}],"person":[{"display":"Bergmann, Frank","given":"Frank","role":"aut","family":"Bergmann"},{"family":"Moldenhauer","role":"aut","given":"Gerhard","display":"Moldenhauer, Gerhard"},{"display":"Herpel, Esther","family":"Herpel","role":"aut","given":"Esther"},{"family":"Gaida","role":"aut","given":"Matthias","display":"Gaida, Matthias"},{"display":"Strobel, Oliver","given":"Oliver","role":"aut","family":"Strobel"},{"given":"Jens","role":"aut","family":"Werner","display":"Werner, Jens"},{"display":"Esposito, Irene","given":"Irene","role":"aut","family":"Esposito"},{"display":"Sebens, Susanne","given":"Susanne","role":"aut","family":"Sebens"},{"role":"aut","given":"Peter","family":"Schirmacher","display":"Schirmacher, Peter"},{"display":"Kern, Michael A.","given":"Michael A.","role":"aut","family":"Kern"}],"id":{"doi":["10.1111/j.1365-2559.2010.03499.x"],"eki":["1831531305"]},"name":{"displayForm":["Frank Bergmann, Gerhard Moldenhauer, Esther Herpel, Matthias M. Gaida, Oliver Strobel, Jens Werner, Irene Esposito, Susanne Sebens Müerköster, Peter Schirmacher & Michael A. Kern"]},"titleAlt":[{"title":"Expression of L one CAM, COX- two, EGFR, c-KIT and Her two/neu in anaplastic pancreatic cancer$dputative therapeutic targets?"}]} | ||
| SRT | |a BERGMANNFREXPRESSION2010 | ||